SectorPharmaceutical
Established Date11/08/2008
Listing Date05/02/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees45
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressDr. Neergaards Vej 5F, DK-2970 Horsholm, Denmark
Business
IntroductionEvaxion A/S was established on August 11, 2008 under the laws of the Kingdom of Denmark. The Company is a clinical-stage company that leverages its proprietary artificial intelligence or AI, technology, engineering expertise and drug development knowledge to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections.
